Search Results
Results found for "Aaron Sato"
Posts (15)
- Newly launched antibody libraries put hard-to-drug targets within reach
Aaron Sato, Chief Scientific Officer at Twist Bioscience, elaborates.
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Aaron McGrath from Takeda. He joins Dr. pockets and druggability 🔹 The role of cryo-EM in capturing fully activated GPCR complexes 📅 Catch Aaron
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
Aaron McGrath from Takeda 🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥
Other Pages (8)
- Ep 16 with Dr. Aaron Sato
Aaron Sato About this episode In this episode of the Dr. GPCR Podcast , I spoke to Dr. Aaron Sato from Twist Biopharma , a vertical within Twist Bioscience . Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. Sato published over 30 peer-reviewed papers and contributed to 40 issued patents in the antibody space Aaron Sato on the web LinkedIn Twitter Google Scholar Twist Bioscience Twist Biopharma Dr.
- Ep 103 with Dr Kathleen Caron
Kathleen Caron About Kathleen M. Caron Kathleen M. Caron, Ph.D. is the Frederik L. Caron received a BS in Biology and BA in Philosophy at Emory University and a PhD at Duke University Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Caron on the web Lab Website Twitter Pubmed Google Scholar Orcid Enjoying the Dr. GPCR Podcast?
- Ep 100 with Dr Caron Tribute Part 1
Caron Tribute Part 1 About Marc Caron Dr. Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American Caron Dr. Jeffrey Benovic (1985) Dr. Michel Bouvier (1985) Dr. Kathleen Caron - Co-host- (1970) Dr.
